Total assets increased 121.7%
Total assets changed +121.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +121.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +57.2% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital / assets changed +12747 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +74.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed -15.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -57.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.